National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Childhood Soft Tissue Sarcoma Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 01/04/2008



Purpose of This PDQ Summary






General Information






Cellular and Histopathologic Classification






Stage Information






Treatment Option Overview






Nonmetastatic Childhood Soft Tissue Sarcoma






Metastatic Childhood Soft Tissue Sarcoma






Recurrent/Progressive Childhood Soft Tissue Sarcoma






Get More Information From NCI







Changes to This Summary (01/04/2008)






More Information



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

President's Cancer Panel Annual Report: 2006-2007

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Changes to This Summary (01/04/2008)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Purpose of This PDQ Summary

Added this new section.

Selected Soft Tissue Sarcomas in Children

Added Lietman et al. as reference 20.

Treatment Option Overview

Added Pappo et al. as reference 28.

Nonmetastatic Childhood Soft Tissue Sarcoma

Added text to state that young patients with MPNST and neurofibromatosis type-1 (NF-1) showed that most patients had large invasive tumors and reponded poorly to chemotherapy.Another series of older patients with MPNST found that those with NF-1 had a worse prognosis than those without NF-1 (cited Ferrari et al. and Hagel et al. as references 40 and 41, respectively).

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov